Background: Higher iron stores, defined by serum ferritin (SF) concentration, may increase malaria risk.
Introduction
The global debate regarding the role of iron in malaria pathology has predominantly focused on the effects of exogenous iron administration on malaria outcomes (1) . This focus is in part a direct and justifiable reaction to a trial carried out in Pemba, Tanzania, in which Sazawal et al. (2) concluded that universal iron supplementation of young children in malaria-endemic settings may increase the risk of adverse health outcomes, including severe morbidity and mortality. An important finding, which has received much less attention, is that the adverse effects in the Pemba trial were not apparent until after 6 mo of daily supplementation, and the effects were restricted to children who had adequate iron status at baseline. This is consistent with emerging evidence suggesting that higher levels of storage iron, even in the absence of exogenous administration, may be associated with adverse malaria outcomes (3) (4) (5) (6) . Amid ongoing efforts to improve the safety of iron interventions in malariaendemic regions, it is critical that the role of body iron status in malaria pathology is understood.
A major challenge with evaluating the association between iron status and malaria is the bidirectionality of their interactions. Ferritin, the recommended marker for defining iron status (7) , is an acute-phase protein for which concentrations are typically considerably elevated as part of the inflammatory response to infections (8) . This study aimed to assess the association between ferritin, corrected and uncorrected for inflammation, and the risk of new malaria episodes.
A secondary objective was to evaluate how age and the serum soluble transferrin receptor (sTfR) modify the ferritin-malaria interaction. The transferrin receptor is expressed on the surface of all cells (with the exception of mature erythrocytes) (9) and is involved in the receipt of iron bound to transferrin. The truncated version of the membrane-bound transferrin receptor, referred to as the sTfR, is present in plasma and is used to define the status of iron delivery to tissues (10, 11) . The rate of transcription, translation, and expression are upregulated, and concentrations are higher, when the delivery of iron for erythropoiesis is interrupted (10, 11) . Because malaria parasites reside in RBCs, any physiologic process that impairs RBC production may affect replication of the blood stage parasites. Therefore, the sTfR may provide a basis to understand whether the ferritin-malaria interaction is driven primarily by iron accumulation or by the status of iron delivery and iron utilization.
Methods

Summary
Data used in this study were collected as part of a randomized trial, primarily designed to assess the efficacy of daily pro-vitamin A supplementation on the vitamin A status of children aged 4-8 y in rural communities of the Mkushi District, located in Central Province, Zambia. Detailed methodology and primary results of the parent trial were published previously (12) . Data collection procedures relevant to the goals of this article are summarized below.
Ethics approval
Ethics approval was obtained from the Institutional Review Board of the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland, and the Ethics Review Committee of the Tropical Disease Research Center (TDRC) in Ndola, Zambia.
Subject and data collection
This study was nested in a cluster-randomized, controlled trial designed to evaluate the efficacy of provitamin A carotenoid-biofortified maize meal consumption in improving the vitamin A status of children aged 4-8 y in Mkushi District, Zambia (registered at clinicaltrials.gov as NCT01695148). The Mkushi District is malaria endemic and has a high burden of anemia (13) (14) (15) . Briefly, we conducted baseline and endline surveys (approximately September 2012 and April 2013, respectively) in the low and high malaria transmission seasons, respectively. At a central assessment site, we collected socioeconomic data and morbidity history and we measured height to the nearest 0.1 cm using a Shorr board and weight to the nearest 0.1 kg with a SECA 874 digital scale. We measured axillary temperature with a digital thermometer and referred children with a high fever (axillary temperature >39.5°C) to the nearest health center. For each child, we used a syringe to draw~7 mL of venous blood into a 10-mL collection tube (Monoject sterile tubes with no additives; Covidien). We used a rapid diagnostic test (RDT) (05FK50 SD Bioline Malaria Ag P.f; Standard Diagnostics) to test for malaria in the field. Children who had a positive RDT result for malaria parasitemia during the baseline and endline assessments were treated with artemether and lumefantrine (Coartem; Novartis) in accordance with Zambian guidelines (16) . Thick and thin venous blood films were prepared using ;2 and 10 mL of blood, respectively. Hemoglobin was assessed using a HemoCue photometer. Blood collection tubes were immediately placed in cooler boxes containing ice packs, were allowed to clot, and were transported to field laboratories for separation into serum by centrifugation. Serum was aliquoted into prelabeled cryovials and stored in liquid nitrogen until transit to the TDRC laboratory in Ndola, Zambia (~120 km away), where they were kept at 280°C until analyzed. All children were given an insecticide-treated bed net at baseline.
Laboratory analyses. Malaria microscopy and serum assays were performed at the TDRC laboratory. Slides were stained with 3% Giemsa, washed, dried, and read by 2 independent microscopists (D Mutale and M Chansa). Where necessary, a third independent reading was performed (by JC) to resolve discordant results. Parasite density was estimated using thick films by counting the number of parasites per 200 white blood cells. A slide was ruled negative if no parasites were detected after counting 200 oil immersion fields. The number of parasites per 1 mL of blood was calculated by assuming 8000 white blood cells/mL of blood. For each positive reading, the corresponding thin film was read to determine the Plasmodium species. Commercial ELISA kits were used to determine serum concentrations of a 1 -acid glycoprotein (AGP; catalog no. ab108854; Abcam), ferritin (catalog no. S-22; Ramco Laboratories, Inc.), and sTfR (catalog no. TFC-94; Ramco Laboratories Inc.). All baseline assessments were repeated at the endline, 6 mo later.
Definition of malaria. The primary outcome was microscopy-based malaria, as defined as a positive thick smear of any density and assessed during the period of high malaria transmission (March 2013).
Definition of iron status. The primary exposure of interest was iron status, as defined by ferritin assessed in the low malaria season (September 2012). We previously showed in this population that ferritin concentrations are elevated in inflammation, especially in the context of concurrent malaria (17) , regardless of underlying iron status. It is therefore recommended to adjust ferritin concentrations by using indicators of inflammation or infection, to control for potential bias. Although there is no standard for correcting inflammation-induced changes in ferritin, it is conventional to used $1 acute-phase proteins in characterizing this potential bias. In this study, inflammation was defined by using AGP (<1 g/L). Because recent evidence suggests that malaria exacerbates changes in inflammation (17) , additional adjustment procedures were implemented to control for the potential effects of baseline malaria on baseline ferritin values. Hence, in our analyses, baseline ferritin concentrations, either corrected or uncorrected for inflammation and malaria, were separately used to define iron status. To generate corrected ferritin values, children were first categorized into 4 groups based on malaria and AGP as follows: reference (AGP #1 g/L and malaria negative), inflammation only (AGP >1 g/L and malaria negative), malaria only (AGP #1 g/L and malaria positive), and malaria with inflammation (AGP >1 g/L and malaria positive). For the purpose of correcting inflammation-and malaria-related changes in ferritin, children were considered to have malaria if they had a positive microscopy or RDT result. Geometric means for the ferritin distributions were estimated within each group. We then calculated ratios of the geometric mean ferritin in each of the malaria-inflammation groups to that of the reference group. Correction factors were established using the inverse of the geometric mean ratios (8) . All individual ferritin values among members of the corresponding groups were multiplied by the groupspecific correction factor to derive an estimate of ferritin assumed to be unaffected by inflammation or malaria exposure. Children were considered to have deficient iron status if their serum ferritin concentrations (corrected or not) were <12 or <15 mg/L, depending on age (<5 or $5 y, respectively). Children were otherwise considered to have adequate iron status. A 3-group iron status definition (informed by exploratory data analyses) was also used, with the adequate iron status category stratified into 2 groups: moderate (#75 mg/L but not deficient) and high (>75 mg/L) ferritin concentrations. To evaluate the potential effect modification by sTfR, we generated a 5-group iron status strata as follows: deficient or reference (as defined above using ferritin), moderate ferritin with high sTfR (>8.3 mg/L), moderate ferritin with normal sTfR (#8.3 mg/L), high ferritin with high sTfR, and high ferritin with normal sTfR. As in the case of ferritin, sTfR was corrected for inflammation and malaria, based on prior evidence from this population (17) .
Sample size and power considerations. Assuming an iron deficiency prevalence of 50% and a 20% malaria prevalence in the group with adequate iron status, 784 children provided a sufficient sample size to detect a 10% difference in malaria incidence (b = 0.1, a = 0.05).
Statistical analyses. To identify potential confounding factors of the association between ferritin and malaria, exploratory analytic techniques were used to evaluate the associations between iron status or malaria and demographic, anthropometric, and biochemical variables. Variables explored included literacy, stunting and underweight, fever, anemia, and use of a bed net or medication. Literacy was defined as the ability to read or write in English or Bemba. Stunting and underweight were defined as height-for-age and weight-for-age z scores, respectively, <22 SDs of the WHO growth standard for children aged <5 y and the growth reference for children aged $5 y (18). Fever was defined as an axillary temperature >37.5°C. Anemia was defined as hemoglobin <11.0 or <11.5 g/dL for children aged <5 y or $5 y, respectively (7). These variables were explored both as continuous and dichotomous variables as necessary. Differences in continuous variables such as age, by iron status, were tested using the t test if the data were normally distributed. Differences in dichotomous variables such as stunting and underweight, by iron status, were tested using the chi-square test.
Skewed data, including ferritin, sTfR, and AGP, were log transformed before parametric tests were performed. We used a modified Poisson regression approach to estimate the incidence rate ratio (IRR) (19, 20) . In all statistical models, the deficient iron status category was considered the reference against which to estimate the malaria risk in all other iron status categories. Separate models were constructed using the measured or inflammation-corrected iron status. As part of the exploratory analyses, models were constructed to examine the presence of statistical interactions (P < 0.1) and evidence of the presence of a threshold ferritin concentration beyond which malaria risk markedly increased. Age-stratified models were constructed, in which children were defined as having deficient, moderate, or high ferritin concentrations (as defined above). A 72-mo age cutoff was chosen because an age interaction was observed at this point. The 3-group ferritin stratification was based on a logistic spline model, which showed that the slope of the ferritin-malaria function significantly changed beyond a ferritin concentration of 75 mg/L (P-interaction < 0.05). We tested for potential effect modification by sTfR.
Potentially confounding variables were included in the final models if the exploratory analyses showed a statistically significant association with either baseline ferritin or endline malaria (P < 0.1) or if the evidence from prior studies suggested the existence of an association with either ferritin or malaria. All multivariate models were adjusted for age at baseline, intervention allocation, reported receipt of a high-dose vitamin A capsule in the past 6 mo, and anemia status at endline. Variables such as bed-net usage and anthropometric status, which were not significantly associated with iron status or malaria, were not included in the final models. Statistical significance was set at P = 0.05. Significance of the interaction terms was set at P = 0.1. All data analyses were conducted with STATA 13 software (StataCorp).
Results
From 1024 children enrolled in the main trial, we included a subset (n = 745) who had complete data for baseline ferritin, AGP, and malaria microscopy results in addition to endline malaria microscopy results. The median age of children included in the analyses was 69 mo (IQR: 25), with roughly one-third aged <5 y and an equal representation of boys and girls ( Table  1) . The prevalence of stunting (30% at baseline) is indicative of the likely presence of risk factors including infections and micronutrient deficiencies, particularly of zinc. One-third of children were anemic at baseline, but the baseline prevalence of iron deficiency was only 8% based on ferritin. Malaria prevalence at baseline (low transmission season) was 19% (95% CI: 16-22%) and 14% (95% CI: 11-16%) as determined by RDT and microscopy, respectively. All cases of positive microscopy at both time points were confirmed to be of the P. falciparum species (data not shown). Although almost all patients with malaria were asymptomatic (prevalence of fever <1% at baseline), ;45% of children had systemic inflammation.
In the dichotomous analyses (Table 2) , the proportion of children with microscopy-defined malaria during the high malaria season was 19% in the group with deficient iron status and 24% in the group with adequate iron status, based on the measured baseline ferritin concentrations. Iron adequacy was associated with a nonsignificant increase in malaria risk of 50% when defined by the measured ferritin values and an increase of 60% when defined by the inflammation-adjusted ferritin concentrations. Exploratory analyses showed that the ferritinmalaria association was age dependent (P-interaction < 0.1), such that a positive correlation between baseline ferritin concentration and the risk of developing a new malaria episode at 6 mo was observed in children aged <72 mo but not older. We also observed a threshold effect, such that malaria risk appeared to increase markedly beyond a baseline ferritin concentration of 75 mg/L (P-interaction < 0.05). In the age-stratified, 3-group analyses (Table 3) , a significantly increased malaria risk (relative to the deficient group) was observed in the high-ferritin group among children aged <72 mo (P < 0.05). The increased risk was observed whether the measured ferritin (IRR: 2.66; 95% CI: 1.10, 6.43) or the inflammation-corrected ferritin (IRR 2.93; 95% CI: 1.17, 7.33) was used in defining iron status (Table 3) . Although relative increments in malaria risk were observed in children in the moderate iron status category (56% increased when measured ferritin was used [P = 0.33] and 92% when inflammation-corrected ferritin was used [P = 0.17]), these differences were not statistically significant (Table 3) . Ferritin did not predict malaria risk in older children (aged >72 mo; Table 3 ). Finally, a secondary analyses, in which the moderate and higher ferritin groups were further stratified by functional iron status (sTfR #8.3 mg/L or >8.3 mg/L) confirmed the 
Discussion
We observed a positive dose-response relation between ferritin concentrations and malaria risk over a 6-mo period in children aged <72 mo. In this same age group, iron adequacy during the low malaria season was associated with an elevated malaria risk during the high malaria season. This association was not observed in older children. Adjustment for inflammation or malaria did not influence these findings. Our data are consistent with findings from previous observational studies in Africa, where iron deficiency appeared to confer protection against malaria (3, 5, 6) . In the first of these studies, Nyakeriga et al. (6) reported that iron deficiency was associated with a 30% reduction in the incidence of clinical malaria in a cohort of Kenyan children aged 8-96 mo. Gwamaka et al. (5) estimated that iron deficiency reduced the odds of incident malaria parasitemia and severe malaria by 23-38% over a 3-y follow-up of Tanzanian children. Jonker et al. (3) reported that iron deficiency was associated with a 45% reduction in incident malaria in Malawian preschool-aged children. Our estimates, which varied by the definition of iron status, translate into a reduction in malaria risk in the range of 7-88% in the group with deficient iron status relative to the group with adequate iron status. Despite a higher frequency of follow-ups in the 3 previous studies, we arrived at similar conclusions. These observational studies are also consistent with secondary analyses from the Pemba trial, which concluded that the adverse effects of iron supplementation were restricted to children who had adequate iron status at baseline (2) . A trial by Zlotkin et al. (4) , however, reported a lower incidence of malaria among children receiving an iron-containing micronutrient powder than a placebo powder. Interestingly, this reduction in malaria was no longer apparent after adjusting for baseline iron status.
Several plausible mechanisms may explain the observed relative increase in malaria risk in children with adequate iron status. Studies in mice confirmed that both the sporozoite and merozoite stages are heavily reliant on iron, and iron deprivation stymies their growth and development (21, 22) . Portugal et al. (23) reported that a hepcidin-induced redistribution of iron from hepatocytes to macrophages after an initial malaria infection significantly reduced the risk of new malaria infections in mice. The process through which the parasites capture and utilize iron is not completely understood, especially considering that most of the intra-and extracellular iron is tightly bound to the ferroproteins ferritin and transferrin, respectively (24, 25) . New evidence points toward a cytosolic labile iron pool (LIP) (26) (27) (28) and the labile iron component of plasma nontransferrin-bound iron (29) as putative iron sources for developing parasites. The LIP has been defined as a transitory form of metabolically active, chelatable, nonbound iron (26, 30) . The LIP hypothesis is supported by several studies showing the inhibitory effects of iron chelators on parasite growth and development (31) (32) (33) (34) . Considering that ferritin concentrations are upregulated by higher concentrations of both LIP (35) and nontransferrinbound iron (29, 36) , iron adequacy, as seen in our study children, may reflect increased iron accessibility and enhanced parasite development. There is also evidence that the apparent protection observed in iron deficiency may be attributable to iron deficiency-induced erythrocyte death and subsequent clearance from the circulation (21) , which would accelerate clearance of parasitized RBCs. The extent to which the early death of RBCs affects the development of new sporozoites emerging from the liver into the circulation is unclear.
It is interesting but not surprising that the positive correlation between ferritin and malaria was only observed in children aged <72 mo. The risk of adverse malaria outcomes is typically highest in young children as a result of their immature immune response (37, 38) . In older children, new parasites may be cleared relatively quickly, regardless of iron status. Conversely, it is also plausible that in younger children, a delayed parasite clearance in the context of iron adequacy may lead to an overall enhancement in parasite replication. More research is needed to understand the specific components of iron metabolism and antimalaria immunity that sustains or suppresses the parasitesÕ growth and survival in both the hepatic and erythrocytic stages of the malaria cycle. Our analyses of the effect modification by sTfR may provide additional clues regarding the physiologic conditions under which higher iron stores precipitate an increased malaria risk. Although higher baseline ferritin values generally predicted a higher malaria risk at endline, the stratified analyses showed that this effect was only statistically significant in the subgroup of children who had higher ferritin values and concurrently normal concentrations of sTfR. A plausible explanation for this observation is that normal sTfR is suggestive of an uninterrupted erythropoiesis. The resulting increase in the population of reticulocytes, the preferred habitat for the Plasmodium parasite, may have contributed to the increase in malaria risk. Conversely, the lower malaria incidence among children with higher or abnormal sTfR values may indicate the presence of systemic inflammation, in which case the iron is sequestered in macrophages and hepatocytes and is hence unavailable to both the parasite and host.
Our study is limited by its observational nature, particularly considering the bidirectionality of the association between malaria and the indicators of iron status. In addition, children who had malaria at baseline were likely at greater risk of malaria at endline. To counter this, all children who had a positive test result for malaria parasitemia at baseline were treated with artemether and lumefantrine to ensure that the cases observed at endline were new cases. We also corrected for inflammation to limit potential misclassification of iron status. This more conservative approach actually increased the strength of the association between ferritin and future malaria risk. Finally, the sTfR concentration modified the ferritin-malaria relationship. Having normal or higher ferritin and a normal sTfR is characteristic of an efficient iron delivery mechanism in the midst of adequacy. Such a phenomenon may ensure the availability of iron to developing sporozoites and merozoites in RBCs. Finally, it is worth noting that these observations were made in a context with an apparently low risk of iron deficiency. Future studies in this field should consider the role of hemoglobinopathies, including sickle cell disease, which are known to modulate both malaria risk and iron metabolism.
We have shown that ferritin concentrations $75 mg/L are associated with an increased risk of malaria in children aged <6 y. The association between ferritin and malaria risk was more pronounced in children with normal sTfR concentrations. Our study has important implications for the future of iron-malaria research and programs. In the wake of the Pemba trial (registered at isrctn.com as ISRCTN59549825), it is justifiably more difficult, on ethical grounds, to conduct trials of iron supplementation or fortification in regions with high malaria transmission. Additional evidence from well-designed observational studies may improve our current understanding of the interactions between iron and malaria and may inform the design of integrated malaria-anemia control programs (39) (40) (41) (42) . Our study has shown that there is a need for more research into the interaction between endogenous iron sources and malaria. Specifically, research is needed to understand whether the ferritin threshold observed here is generalizable to other pediatric populations in malaria-endemic regions.
